HHealthcare stocks traded mostly higher on Friday afternoon, with the NYSE Health Care index rising 0.3% and the ETF Health Care Select Sector SPDR (XLV) rising 0.1%.
The Nasdaq Biotechnology Index slipped 0.1%.
In company news, Nutriband (NTRB) nearly tripled in value, recently climbing nearly 165%, after it said its drug abuse deterrent technology Aversa had received a full patent from the Office. of South Korea’s intellectual property.
Vir Biotechnology (VIR) added 3% after the company said new preclinical data showed its sotrovimab monoclonal antibody retains neutralizing activity in vitro against all known variants of COVID-19, including omicron. Vir developed sotrovimab in partnership with GlaxoSmithKline (GSK) and received emergency use authorization to treat mild to moderate COVID-19 from the United States Food and Drug Administration.
Sintx Technologies (SINT) fell 4.9%. The medical device company has said Scientific Director Bryan McEntire will retire at the end of the year, becoming Scientific Director Emeritus. Ryan Bock, currently director of research and development at Sintx, will succeed McEntire, the company said.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.